Does AROMASIN Cause Second primary malignancy? 5 Reports in FDA Database

Q: Does AROMASIN cause Second primary malignancy?

5 reports of Second primary malignancy have been filed with the FDA for AROMASIN, representing 3.7% of all AROMASIN adverse event reports.

Q: How dangerous is Second primary malignancy from AROMASIN?

Of 5 reports, 4 (80.0%) resulted in death and 1 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with AROMASIN. This represents 3.7% of all adverse event reports for AROMASIN.

Reports of Second primary malignancy with AROMASIN

3.7%

of all AROMASIN reports

Deaths

Hospitalizations

How Dangerous Is Second primary malignancy From AROMASIN?

Of the 5 reports, 4 (80.0%) resulted in death, 1 (20.0%) required hospitalization.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AROMASIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does AROMASIN Cause?

Disease progression (23) Breast cancer (22) Arthralgia (11) Fatigue (10) Insomnia (9) Headache (8) Pain (8) Diarrhoea (7) Malaise (7) Neoplasm malignant (7)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which AROMASIN Alternatives Have Lower Second primary malignancy Risk?

AROMASIN vs ARSENIC TRIOXIDE AROMASIN vs ARTEMETHER\LUMEFANTRINE AROMASIN vs ARTESUNATE AROMASIN vs ARTICAINE\EPINEPHRINE AROMASIN vs ASCIMINIB

AROMASIN Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy AROMASIN Demographics